 Codexis, Inc. CDXS, a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce a partnership to engineer enzymes to deliver differentiated and cost-effective solutions for the enzymatic synthesis of DNA. Under the terms of the agreement, Codexis will purchase 1 million in Series A preferred stock of Molecular Assemblies, and John Nicols, Codexis President and CEO will join the Molecular Assemblies Board of Directors. 